Assessment of the effectiveness of additional Risk Minimisation Measures (aRMMs) among pharmacists for provision of Estradiol hemihydrate 10 micrograms vaginal tablets in a community pharmacy setting

First published 29/07/2024

Last updated 29/07/2024

EU PAS number:

EUPAS1000000274

Study

Finalised

Documents

Study protocol

Initial protocol

Gina NIS Protocol v6 eu-pas-reg Redacted.pdf

English (743.18 KB - PDF)View document

Study results

Gina NIS Report eu-pas-reg Redacted.pdf

English (4.55 MB - PDF)View document

Study report

Other information

Secondary tabs